Reduction of tumor necrosis factor production by splenocytes from v-Ha-ras oncogene-bearing mice

G J Chen1, L L Colombo, M C Lopez

  • 1Department of Family and Community Medicine, University of Arizona, Tucson 85624.

Cancer Letters
|November 1, 1993
PubMed

Insights

Mice with the v-Ha-ras oncogene showed reduced tumor necrosis factor (TNF) production. This suggests oncogenes may impact the immune system, affecting cytokine release like TNF.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • The v-Ha-ras oncogene is implicated in various cancers.
  • Cytokine production, such as tumor necrosis factor (TNF), is crucial for immune responses.
  • The interaction between oncogenes and immune function requires further investigation.

Purpose of the Study:

  • To investigate the effect of the activated v-Ha-ras oncogene on cytokine production in mice.
  • To compare TNF and gamma-interferon (IFN) levels in Oncomice versus control mice.

Main Methods:

  • Inbred Oncomice (carrying v-Ha-ras) and FVB mice (control) were studied over 6 months.
  • Splenocytes were isolated and stimulated in vitro.
  • Quantification of TNF and IFN release was performed.

Main Results:

  • Splenocytes from Oncomice produced significantly less TNF compared to control FVB mice.
  • A non-significant trend towards decreased IFN release was observed in Oncomice.
  • These findings indicate a specific impact of the v-Ha-ras oncogene on TNF production.

Conclusions:

  • The activated v-Ha-ras oncogene is associated with decreased TNF production in mice.
  • Oncogenes may play a regulatory role in the immune system by modulating cytokine release.
  • Further research is warranted to elucidate the mechanisms underlying oncogene-mediated immune modulation.

Related Concept Videos